Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Capital Employed (2017 - 2026)

Organogenesis Holdings has reported Return on Capital Employed over the past 9 years, most recently at 9.84% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 1017.0% year-over-year to 9.84%; the TTM value through Dec 2025 reached 9.84%, up 1017.0%, while the annual FY2025 figure was 9.97%, 1029.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 9.84% at Organogenesis Holdings, up from 2.12% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 31.88% in Q2 2021 and troughed at 5.79% in Q1 2025.
  • A 5-year average of 8.01% and a median of 5.43% in 2022 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: surged 5084bps in 2021 and later tumbled -1852bps in 2022.
  • Year by year, Return on Capital Employed stood at 22.28% in 2021, then tumbled by -74bps to 5.9% in 2022, then plummeted by -44bps to 3.29% in 2023, then plummeted by -110bps to 0.33% in 2024, then surged by 3127bps to 9.84% in 2025.
  • Business Quant data shows Return on Capital Employed for ORGO at 9.84% in Q4 2025, 2.12% in Q3 2025, and 5.74% in Q2 2025.